It is a business outsourcing private limited company based in Bangalore, Karnataka, India, established in 2013.
2013 | Bangalore, Karnataka, India | ActiveCopernicium Pharmaceuticals Private Limited, a active private limited company, was established on 10 December 2013 in Bangalore, Karnataka, India. Engaging in business & it consulting within the professional, scientific and technical sector, it holds CIN: U24230KA2013PTC072419. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹3.60 Cr and a paid-up capital of ₹3.58 Cr.
It upholds a compliant status. Employing 8 professional, Its leadership includes Salim Sadiq Shaikh (Director), Akash Suresh Puranik (Director). Past directors included Abhijit Govindrao Kale. It holds ₹29.21 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Sree Veerabhadreshwara Swamy Enclave, No. 1215, 24Th Main, 11Th Cross, Hsr Layout, 1St S, Ector, Bangalore, Karnataka, 560102.
U24230KA2013PTC072419
072419
10 December 2013
₹3.60 Cr
₹3.58 Cr
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into Copernicium Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Salim Sadiq Shaikh | Director | 10 Dec 2013 | Current |
| Akash Suresh Puranik | Director | 23 Dec 2013 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 30 Mar 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Copernicium Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 13.78% decrease. The company also saw a slight improvement in profitability, with a 4.34% increase in profit. The company's net worth Soared by an impressive increase of 173.61%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Copernicium Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹292,068,366.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Nov 2022 | Others | ₹28.00 Cr | Open |
| 01 Sep 2021 | Hdfc Bank Limited | ₹2.97 M | Open |
| 16 Sep 2020 | Hdfc Bank Limited | ₹1.00 M | Open |
| 28 Aug 2020 | Hdfc Bank Limited | ₹3.70 M | Open |
| 28 Aug 2020 | Hdfc Bank Limited | ₹1.00 M | Open |
Explore comprehensive loan charge details -
Copernicium Pharmaceuticals has a workforce of 8 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Copernicium Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Copernicium Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Copernicium Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Copernicium Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore. was recorded as a recent event.
Progress on A charge with Others of Rs. 28.00 Cr registered on 28 Nov 2022 with Charge ID 100649377 was modified on 28 Jun 2023. was documented.
Progress on A charge with Others amounted to Rs. 28.00 Cr with Charge ID 100649377 was registered on 28 Nov 2022. was documented.
The activity A charge with Hdfc Bank Limited amounted to Rs. 0.30 Cr with Charge ID 100478369 was registered on 01 Sep 2021. was completed.
Progress on A charge with Hdfc Bank Limited amounted to Rs. 0.10 Cr with Charge ID 100429488 was registered on 16 Sep 2020. was documented.
The CIN of Copernicium Pharmaceuticals Private Limited is U24230KA2013PTC072419.
Copernicium Pharmaceuticals Private Limited is headquartered at Sree Veerabhadreshwara Swamy Enclave, No. 1215, 24Th Main, 11Th Cross, Hsr Layout, 1St S, Ector, Bangalore, Karnataka, 560102.
Copernicium Pharmaceuticals Private Limited was incorporated on 10 December 2013.
The current directors of Copernicium Pharmaceuticals Private Limited are
The primary industry of Copernicium Pharmaceuticals Private Limited is Professional, Scientific And Technical.
Copernicium Pharmaceuticals Private Limited is unlisted.
The authorized capital of Copernicium Pharmaceuticals Private Limited is ₹3.60 Cr, and the paid-up capital is ₹3.58 Cr.
The compliance status of Copernicium Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX